跳至主要内容
临床试验/JPRN-UMIN000007054
JPRN-UMIN000007054已完成2 期

Phase II study of nedaplatin for advanced or relapsed squamous cell lung cancer in chemo-naive elderly patients - Phase II study of nedaplatin for advanced squamous cell lung cancer in elderly patients

Shizuoka Cancer Center0 个研究点目标入组 25 人开始时间: 2012年1月12日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
75years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with brain metastasis in need of steroid or anticonvulsant. 2) Less than 4 weeks after curative radiotherapy to primary lesion or less than 2 weeks after palliative radiotherapy. 3) History of active double cancer. 4) Patients with superior vena cava syndrome. 5) Uncontrollable pleural effusion, pericardial effusion or ascites. 6) History of uncontrollable hypertension, diabetes mellitus, active angina pectoris, active gastrointestinal hemorrhage, recent cardiac incompetence, recent myocardial infarction and active viral infection (except viral hepatitis). 7) Interstitial shadow of UIP (usual interstitial pneumonia) pattern on chest CT. 8) History of severe drug allergy. 9) History of severe psychiatric disease. 10) Patients whose participation in the trial is judged to be inappropriate by the attending doctor.

研究者

相似试验